| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -2.9 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.086 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 2.6 | 0.007 |